Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

Small-cell lung cancer (SCLC) is often associated with paraneoplastic syndromes. To assess the role of anti-neuronal autoantibodies (NAAs) as biomarkers of treatment outcome, we assessed NAAs in serial samples from SCLC patients treated with chemoimmunotherapy compared to chemotherapy alone. We eval...

Full description

Bibliographic Details
Main Authors:	M. Hardy-Werbin, O. Arpí, A. Taus, P. Rocha, D. Joseph-Pietras, L. Nolan, S. Danson, R. Griffiths, M. Lopez-Botet, A. Rovira, J. Albanell, C. H. Ottensmeier, E. Arriola
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-02-01
Series:	OncoImmunology
Subjects:	anti-hu anti-yo autoantibodies anti-sox-1 ipilimumab paraneoplastic syndrome small cell lung cancer
Online Access:	http://dx.doi.org/10.1080/2162402X.2017.1395125

Similar Items

Attention deficit hyperactivity disorder and anti-Purkinje autoantibodies: no link?
by: Fatih Hilmi Cetin, et al.
Published: (2019-10-01)

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer
by: Max Hardy-Werbin, et al.
Published: (2019-06-01)

Paraneoplastic cerebellar degeneration associated with ovarian adenocarcinoma: A case report and review of literature
by: Pushpendra Nath Renjen, et al.
Published: (2018-01-01)

MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review
by: Vito A. G. Ricigliano, et al.
Published: (2018-01-01)

IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2016-12-01)

Paraneoplastic cerebellar degeneration in a patient with ovarian cancer
by: Hung-Ju Chien, et al.
Published: (2015-06-01)

Autoimmune Anti-Hu Antibody Limbic Encephalopathy
by: J Gordon Millichap
Published: (2013-08-01)

Trigeminal Neuralgia as the First Clinical Manifestation of Anti-Hu Paraneoplastic Syndrome Induced by a Borderline Ovarian Mucinous Tumor
by: Hossein Kalanie, et al.
Published: (2014-01-01)

Paraneoplastic Brainstem Encephalitis Associated with Anti-Hu Antibody
by: Jee Eun Yoon, et al.
Published: (2015-12-01)

A Rare Case of Ovarian Cancer Presenting with Paraneoplastic Cerebellar Degeneration and Limbic Encephalitis
by: Wei-Hua Li, et al.
Published: (2015-01-01)

A Rare Case of Anti-Yo Antibody Associated Paraneoplastic Sensory Polyganglionopathy in a Patient with Ovarian Cancer
by: Syed Hammad Tirmazy, et al.
Published: (2014-06-01)

Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report
by: Sandra Deac, et al.
Published: (2021-02-01)

Paraneoplastic cerebellar degeneration in a patient with anti-Yo antibodies and prostate adenocarcinoma
by: Ekaterina S. Koroleva, et al.
Published: (2017-10-01)

Gamma-aminobutyric acid-B limbic encephalitis and asystolic cardiac arrest: a case report
by: Christopher A. Ovens, et al.
Published: (2017-12-01)

AUTOANTIBODIES IN SYSTEMIC SCLEROSIS: SPECTRUM, CLINICAL ASSOCIATIONS, AND PROGNOSTIC VALUE
by: L. P. Ananyeva, et al.
Published: (2016-03-01)

Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538
by: Oliver Klein, et al.
Published: (2021-01-01)

Paraneoplastic cerebellar degeneration heralding recurrence of fallopian tube adenocarcinoma: A case report and literature review
by: Abigail Cain, et al.
Published: (2020-08-01)

Paraneoplastic cerebellar degeneration in a patient with a primary fallopian tube adenocarcinoma. A case report and brief review
by: Mario Campero, et al.
Published: (2017-05-01)

A Rare Case of Sensory Neuropathy Associated with Transitional Cell Carcinoma of the Bladder
by: Sujitha Ketineni, et al.
Published: (2020-11-01)

Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-yo antibody mediated paraneoplastic cerebellar degeneration
by: Amita Bhargava, et al.
Published: (2014-01-01)

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
by: Ahmad Tarhini, et al.
Published: (2018-10-01)

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
by: George Zarkavelis, et al.
Published: (2020-03-01)

Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab
by: Katjana S. Schwab, et al.
Published: (2018-01-01)

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations
by: Raquel Ruiz-García, et al.
Published: (2019-04-01)

Anti-Yo and anti-glutamic acid decarboxylase antibodies presenting in carcinoma of the uterus with paraneoplastic cerebellar degeneration: a case report
by: Panegyres Peter K, et al.
Published: (2012-06-01)

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab
by: Anders H. Kverneland, et al.
Published: (2018-05-01)

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
by: Amirali Karimi, et al.
Published: (2021-03-01)

Intestinal pseudo-obstruction: An important diagnostic challenge
by: Carmen Salvador-Coloma, et al.
Published: (2015-09-01)

Autoantibodies in Spondyloarthritis, Focusing on Anti-CD74 Antibodies
by: Yuan Liu, et al.
Published: (2019-01-01)

Autoantibodies Against C3b—Functional Consequences and Disease Relevance
by: Vasil V. Vasilev, et al.
Published: (2019-01-01)

Autoantibodies in Renal Diseases – Clinical Significance and Recent Developments in Serological Detection
by: Gianna Mastroianni-Kirsztajn, et al.
Published: (2015-05-01)

Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments
by: Anastasia Zekeridou, et al.
Published: (2019-04-01)

Anti-Hu Antibody-Associated Adie's Pupil and Paraneoplastic Sensorimotor Polyneuropathy Caused by Primary Mediastinal Small Cell Carcinoma
by: Lei Zhang, et al.
Published: (2019-11-01)

Corrigendum: Autoantibodies in renal diseases – clinical significance and recent developments in serological detection
by: Gianna Mastroianni-Kirsztajn, et al.
Published: (2020-03-01)

Real‐world survival of patients with advanced BRAF V600 mutated melanoma treated with front‐line BRAF/MEK inhibitors, anti‐PD‐1 antibodies, or nivolumab/ipilimumab
by: Justin C. Moser, et al.
Published: (2019-12-01)

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides
by: Peter Lamprecht, et al.
Published: (2018-04-01)

Autoantibodies in systemic vasculitis
by: Alexandre Wagner Silva De Souza
Published: (2015-04-01)

Association between anti-thyroid peroxidase and anti-cytokeratin 18 autoantibodies and bronchial asthma in women
by: Hala A. Mohammad, et al.
Published: (2016-01-01)

Bench to bedside review of myositis autoantibodies
by: Boaz Palterer, et al.
Published: (2018-03-01)

Antinuclear antibodies (ANA) patterns in paraneoplastic cerebellar degeneration during the course of disease and treatment protocols – A case report
by: A. Ćerimagić, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_2d086hp88ha6elv3cs517mthpg